Role of Home Blood Pressure Monitoring in Overcoming Therapeutic Inertia and Improving Hypertension Control in Mexico

Main Article Content

Hector Galvan Oseguera
Martin Rosas Peralta
Jose Manuel Enciso Muñoz
ANCAM group for HBPM

Abstract

Hypertension remains the most common modifiable cardiovascular risk factor, however, control of hypertension rates remain dismal. Home blood pressure (BP) monitoring has the potential to improve the control of hypertension. Home BP monitoring is now defended evenly for the evaluation and management of hypertension. This paper shows the experience of the National Association of Mexican Cardiologist in a group of patients with hypertension under drug treatment to evaluate the control in a real world clinical practice in Mexico. One hundred and fifty one patients were included. They were followed during two weeks with three home measurements at day (8:00, 14:00 and 20:00hr). An Ambulatory blood pressure of 24hr was performed at the middle of study. At the end of the study 36% (54/151) patients still uncontrolled by systolic blood pressure (>135 mmHg) and 31% by diastolic blood pressure similar results were detected by ambulatory blood pressure. During afternoon and night uncontrolled values were more common. Home blood pressure monitoring, results in a better form to detect uncontrolled patients and help clinical judgment to adjust pharmacological therapy. This practice should be recommended in Mexico.

Article Details

Oseguera, H. G., Peralta, M. R., Muñoz, J. M. E., & group for HBPM, A. (2018). Role of Home Blood Pressure Monitoring in Overcoming Therapeutic Inertia and Improving Hypertension Control in Mexico. Annals of Clinical Hypertension, 2(1), 017–023. https://doi.org/10.29328/journal.ach.1001007
Research Articles

Copyright (c) 2018 Oseguera HG, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults. Hypertension. 2017. Ref.: https://goo.gl/qYWNMa

Julius S. Home blood pressure monitoring: advantages and limitations. J Hypertens. 1991; 9: 41-46. Ref.: https://goo.gl/BgU1mu

Burns-Cox CJ, Russel Rees J, Wilson RSE. Pilot study of home measurement of blood pressure by hypertensive patients. BMJ. 1975; 3: 80. Ref.: https://goo.gl/B5Mv7x

Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ. 2004; 329: 145. Ref.: https://goo.gl/giCB3W

Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Mexico. Ref.: https://goo.gl/XuQKaF

The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997; 157: 2413-2446.

Pickering TG, Devereux RB. Ambulatory blood pressure monitoring as a predictor of cardiovascular risk. Am Heart J. 1987; 114: 925-928. Ref.: https://goo.gl/xRVTvc

O’Brien E, O’Malley K. Overdiagnosing hypertension. BMJ. 1988; 297: 1211-1212. Ref.: https://goo.gl/jLSMTC

Haynes RB, Sackett DL, Gibson ES, Taylor DW, Hackett BC, et al. Improvement in medication compliance in uncontrolled hypertension. Lancet. 1976; 1: 1265-1268. Ref.: https://goo.gl/y4Z1Tf

Soghikian K, Casper SM, Fireman BH, Hunkeler EM, Hurley LB, et al. Home blood pressure monitoring. Effect on use of medical services and medical care costs. Med Care. 1992; 30: 855-865. Ref.: https://goo.gl/oYCvgQ

O’Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: The Omron HEM-705 CP, Philips HP5332 and Nissei DS-175. Blood Pressure Monitoring 1996; 1: 55-61.

Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ. 1993; 306: 983-987. Ref.: https://goo.gl/buV7mg

Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995; 13: 1377-1390. Ref.: https://goo.gl/zB6fBw

Pickering TG. Blood pressure variability and ambulatory monitoring. Curr Opin Nephrol Hypertens. 1993; 2: 380-385. Ref.: https://goo.gl/8jSGgD

Brueren MM, Schouten HJ, de Leeuw PW, van Montfrans GA, van Ree JW. A series of self-measurements by the patient is a reliable alternative to ambulatory blood pressure measurement. Br J Gen Pract. 1998; 48: 1585-1589. Ref.: https://goo.gl/HqESEn

HMSO. Morbidity Statistics from General Practice 1991-1992. London: Stationery Office. 1995.

Sever P. How well are we managing blood pressure? Lancet. 1994; 344: 1019-1020. Ref.: https://goo.gl/3Jbhp9

Aylett M, Creighton P, Jachuck S, Newrick D, Evans A. Blood pressure control of drug treated hypertension in 18 general practices. J Hum Hypertens. 1996; 10: 547-550. Ref.: https://goo.gl/JKgQep

Mashru M, Lant A. Interpractice audit of diagnosis and management of hypertension in primary care: educational intervention and review of medical records. BMJ. 1997; 314: 942-946. Ref.: https://goo.gl/x6riwF

Prasad N, Isles C. Ambulatory blood pressure monitoring: a guide for general practitioners. BMJ. 1996; 313: 1535-1541. Ref.: https://goo.gl/V5R6um

Sega C, Casana G, Pagani R, Bravi C, Vito G De, et al. Ambulatory and home blood pressure reference values: the PAMELA Study. J Hypertens. 1993; 11: 481. Ref.: https://goo.gl/L44wus

Aylett MJ. The use of home blood pressure measurements to diagnose white coat hypertension in general practice. J Hum Hypertens. 1996; 10: 17-20. Ref.: https://goo.gl/8e7zR1

McGrath BP. Is white-coat hypertension innocent? Lancet. 1996; 348: 630. Ref.: https://goo.gl/3PnRmw

Mancia G, Zanchetti A. White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next? J Hypertens. 1996; 14: 1049-1052. Ref.: https://goo.gl/soM9Ag

Spence JD, Lacourciere Y, Guibert R, et al. Is it safe to withhold treatment in white coat hypertension? J Hypertens. 1998; 16: 27055-27055.

Hall CL, Higgs CMB, Notarianni L. Value of patient recorded home blood pressure series in distinguishing sustained from office hypertension: effects on diagnosis and treatment of mild hypertension. J Hum Hypertens. 1990; 4: 9-13. Ref.: https://goo.gl/meky8h

Harrison DW, Crews WD Jr. The Takeda Model UA-751 blood pressure and pulse rate monitor. Biomed Inst Tech. 1992; 26: 325-327. Ref.: https://goo.gl/Wodhce

Gaudemaris. Home blood pressure: variability, comparison with office readings and proposal for reference values. J Hypertens. 1994; 12: 831-838. Ref.: https://goo.gl/MKgujS

Chatellier G, Dutrey-Dupagne C, Vaur L, Zannad F, Genès N, et al. Home blood pressure measurement in general practice (the SMART study). Am J Hypertens. 1996; 9: 644-652. Ref.: https://goo.gl/487FfT

Celis H, De Cort P, Fagard R, Thijs L, Staessen JA. For how many days should blood pressure be measured at home in older patients before steady levels are obtained? J Hum Hypertens. 1997; 11: 673-677. Ref.: https://goo.gl/5ouFsx

O’Brien E. Review: A century of confusion; which bladder for accurate blood pressure measurement? J Hum Hypertens. 1996; 10: 565-572. Ref.: https://goo.gl/8MpD49

Donner-Banzhoff N, Chan Y, Szalai JP, Hilditch J. ‘Home hypertension’: exploring the inverse white coat response. Br J Gen Pract. 1998; 48: 1491-1495. Ref.: https://goo.gl/yxCT9V